-
January 15, 2013
Shares of Celgene Corporation (CELG) hit a 52-week high of $97.71 almost at the end of the trading session on Jan ...
-
January 14, 2013
Gilead Sciences (GILD) recently provided an update regarding its chronic hepatitis C virus (HCV) pipeline. We ...
-
January 03, 2013
This morning, the market has been relatively quiet. The Nasdaq remains relatively unchanged; the S&P 500 is ...
-
December 28, 2012
Biotech stocks have been major outpeformers in 2012.
-
December 27, 2012
It's been a bad day for the market after the morning's trading. The Nasdaq is down 0.7%; the S&P 500 is trading down ...
-
December 24, 2012
The market is having a bad day so far: the Nasdaq is trading down 0.2%; the S&P 500 has declined 0.3%; and the Dow ...
-
December 24, 2012
The market has been slipping so far today. The Nasdaq has declined 0.2%; the S&P 500 is trading down 0.3%; and the ...
-
December 12, 2012
Johnson & Johnson's (JNJ) Janssen recently announced that the FDA has granted approval for the label expansion of ...
-
December 04, 2012
So far today, the Nasdaq is trading down 0.5%, the S&P 500 has slipped 0.3% and the Dow is unchanged. The healthcare ...
-
December 03, 2012
After the morning's trading, the Nasdaq is up 0.2%, the S&P 500 has declined 0.1% and the Dow is trading down 0.2%. ...
-
November 20, 2012
Johnson & Johnson's (JNJ) Janssen-Cilag International NV recently received a positive opinion from the Committee for ...
-
November 15, 2012
The market is currently down, with the Nasdaq falling 0.4%, the S&P 500 decreasing 0.3% and the Dow declining 0.3%. ...
-
November 14, 2012
The market is having a bad day so far. The Nasdaq has decreased 0.4%; the S&P 500 has fallen 0.5%; and the Dow is ...
-
November 13, 2012
Medivation Inc. (MDVN) reported a third quarter loss of 6 cents per share, narrower than the Zacks Consensus ...
-
November 09, 2012
The Nasdaq has risen 0.9%, the S&P 500 has moved up 0.5% and the Dow is trading up 0.2%, marking a bad morning for ...
-
November 06, 2012
Dendreon Corporation (DNDN) reported third quarter 2012 adjusted loss of 86 cents per share, wider than the Zacks ...
-
November 05, 2012
Dendreon has made progress with its expenses, but the sluggish revenue growth is still the major problem.
-
November 02, 2012
The Nasdaq remains relatively unchanged, the S&P 500 has decreased 0.2% and the Dow has declined 0.3% after the ...
-
October 11, 2012
We are maintaining our Neutral recommendation on Dendreon Corporation (DNDN) with a target price of $4.75. The stock ...
-
October 08, 2012
The Nasdaq has fallen 1%, the S&P 500 has declined 0.4% and the Dow is trading down 0.3%, marking a bad morning for ...
